"Having good market intelligence is no longer optional in this day and age"
Rakesh Pabbi - Senior Partner
Viewing entries in
Pharmaceuticals
There’s a new life-sciences-focused consulting firm in town. Founded by a duo with about half a century’s worth of experience in biopharma and medtech between them, Santander Pharma Consulting—no relation to the major banking firm—stepped into the spotlight with a launch announcement Tuesday.
Regeneron has formed a corporate venture capital unit with $100 million a year to invest over the next five years in “biopharmaceutical, healthcare, and health technology” start-ups.
Global IT services and consulting major Cognizant is tapping generative AI (gen AI) technology along with the Nvidia BioNeMo platform to help improve productivity of drug discoveries and speed up its market reach pushing growth in its health sciences vertical.
A Bain & Company survey signals a significant transformation in the pharmaceutical sector's engagement with generative artificial intelligence (AI), moving beyond experimentation to widespread implementation.
